Breast cancer genomics and immuno-oncological markers to guide immune therapies

Seminars in Cancer Biology
D HammerlR Debets

Abstract

There is an increasing awareness of the importance of tumor - immune cell interactions to the evolution and therapy responses of breast cancer (BC). Not surprisingly, numerous studies are currently assessing the clinical value of immune modulation for BC patients. However, till now durable clinical responses are only rarely observed. It is important to realize that BC is a heterogeneous disease comprising several histological and molecular subtypes, which cannot be expected to be equally immunogenic and therefore not equally sensitive to single immune therapies. Here we review the characteristics of infiltrating leukocytes in healthy and malignant breast tissue, the prognostic and predictive values of immune cell subsets across different BC subtypes and the various existing immune evasive mechanisms. Furthermore, we describe the presence of certain groups of antigens as putative targets for treatment, evaluate the outcomes of current clinical immunotherapy trials, and finally, we propose a strategy to better implement immuno-oncological markers to guide future immune therapies in BC.

Citations

Dec 19, 2019·Pediatric Blood & Cancer·Michelle A FortierZeev N Kain
Dec 8, 2019·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Bo CaiJun Zhang
Aug 11, 2019·Aging·Qian WangXiufeng Cao
Mar 19, 2019·Frontiers in Immunology·Mariana Segovia-Mendoza, Jorge Morales-Montor
Aug 4, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Marie Colombe AgahozoCarolien H M van Deurzen
Aug 19, 2020·Cardiovascular and Interventional Radiology·Maciej PowerskiMaciej Pech
Jul 18, 2018·Biosensors·Jingyi QiuTianfu Wu
Jun 28, 2018·Frontiers in Cell and Developmental Biology·Elizabeth A ComenMaria Kleppe
Jun 20, 2019·Frontiers in Pharmacology·Xin ZhaoDayong Cai
Apr 23, 2020·International Journal of Molecular Sciences·Marta GomarascaGiovanni Lombardi
May 16, 2020·NPJ Breast Cancer·Zuzana KosUNKNOWN International Immuno-Oncology Biomarker Working Group
Oct 28, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dora HammerlJohn W M Martens
Jan 14, 2021·International Journal of Molecular Sciences·Hsing-Ju Wu, Pei-Yi Chu
Dec 12, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M A FranzoiM Piccart
Feb 2, 2021·International Journal of Cancer. Journal International Du Cancer·Nancy M Y TengStephen D Robinson
May 29, 2020·Seminars in Cancer Biology·Kah Keng Wong
Nov 20, 2020·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·F WuX Zhang
Dec 15, 2020·Current Breast Cancer Reports·Jamaal L James, Justin M Balko
Mar 6, 2021·Cell·William C HahnUNKNOWN Cancer Target Discovery and Development Network
Feb 13, 2021·NPJ Breast Cancer·Zuzana KosUNKNOWN International Immuno-Oncology Biomarker Working Group
Mar 7, 2021·International Journal of Molecular Sciences·Nuno LopesCatarina Brito
Mar 20, 2021·Seminars in Cancer Biology·Rui ZhangSuling Liu
Nov 8, 2019·Seminars in Cancer Biology·Monica BenvenutoRoberto Bei
Feb 10, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard G VileJose S Pulido
Jul 3, 2021·Life·Srikanth Umakanthan, Maryann M Bukelo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antigenic Modulation

Antigenic modulation occurs when an antibody cross-links antigens on a cell surface, causing the antigens to become internalized. This can lead to therapeutic failure of monoclonal antibodies as the expression of the antigen becomes decreased on target cells. Find the latest research on antigenic modulation here.

Cancer Genomics (Keystone)

Cancer genomics approaches employ high-throughput technologies to identify the complete catalog of somatic alterations that characterize the genome, transcriptome and epigenome of cohorts of tumor samples. Discover the latest research using such technologies in this feed.